Cargando…
Racial and ethnic differences in capecitabine toxicity in patients with gastrointestinal tract cancers
BACKGROUND: Capecitabine is used as a first-line treatment for gastrointestinal (GI) tract cancers. Common toxicities of capecitabine include diarrhea and hand-foot syndrome, which frequently require dose reduction, interruption, or discontinuation. While racial and ethnic differences in capecitabin...
Autores principales: | Brazelton, Alicia, Yande, Soham, Pope, Rita, Johnson, Michael L., Musher, Benjamin, Trivedi, Meghana V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Gastroenterology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922257/ https://www.ncbi.nlm.nih.gov/pubmed/35479584 http://dx.doi.org/10.20524/aog.2022.0688 |
Ejemplares similares
-
Targeting cancers in the gastrointestinal tract: role of capecitabine
por: Saif, Muhammad Wasif
Publicado: (2009) -
Racial/Ethnic Disparities and Survival Characteristics in Non-Pancreatic Gastrointestinal Tract Neuroendocrine Tumors
por: Goksu, Suleyman Yasin, et al.
Publicado: (2020) -
Identifying the predictors of adherence to oral endocrine therapy in racial/ethnic minority patients with low socioeconomic status
por: Rahimi, Sama, et al.
Publicado: (2022) -
Elucidating the role of the gastrointestinal microbiota in racial and ethnic health disparities
por: Byrd, Doratha A., et al.
Publicado: (2020) -
Adherence to oral endocrine therapy in racial/ethnic minority patients with low socioeconomic status before and during the COVID-19 pandemic
por: Rahimi, Sama, et al.
Publicado: (2023)